Top Videos
ESMO Vision stories of Integrated Cancer Care: Verna Vanderpuye, Ghana

"I think ESMO is poised to do that and I think we have a bright future ahead of us," says ESMO member Verna Vanderpuye from Ghana.

What is the Evidence that Fecal Microbiota Transplantation Can Cure GvHD?

Mette Hazenberg, Amsterdam UMC discusses evidence that fecal microbiota transplantation can cure GvHD.



What is the Evidence that Fecal Microbiota Transplantation Can Cure GvHD?

Mette Hazenberg, Amsterdam UMC discusses evidence that fecal microbiota transplantation can cure GvHD.

Leukemia, Lymphoma, Myeloma, and Immunotherapy with Dr. Philip Greenberg

Dr. Philip Greenberg discusses how immunotherapy works for blood cancers, promising immunotherapy clinical trials, as well as potential side effects.

Colorectal Cancer and Immunotherapy with Dr. Scott Kopetz

Dr. Scott Kopetz discusses the latest breakthroughs and future promise of immunotherapy for colorectal cancer patients.

ESMO Vision Stories of Sustainable Cancer Care: Andrea Sbrana

Is statistically significant the same as clinically significant? The ESMO-MCBS has been thought to try and answer this question even when talking about newer treatments, explains Andrea Sbrana.



New Approaches for AML Patients Who Are Not Candidates for Intensive Therapy

Dr Stéphane de Botton discusses novel treatment approached for patients with acute myeloid leukemia who are not candidates for intensive therapy.

The Role of MRD in AML

Dr Jacqueline Cloos talks on the role of measurable residual disease as a prognostic factor in the management of acute myeloid leukemia.

How Molecular Testing Has Transformed AML Treatment Options

Dr David Sallman explains how molecular testing has transformed AML care, including a discussion of risk assessment and the role of next-generation sequencing.

Treatment Cessation Using Venetoclax-Based Therapy for Older Patients With AML

Dr Andrew Wei discusses the combination of venetoclax with low-dose therapy as a new standard of care for older patients with AML who have not received prior treatment...

The Importance of Induction Chemotherapy in the AML Treatment

Dr Jeffrey Lancet gives an overview of the importance of induction chemotherapy in the treatment of acute myeloid leukemia.



IELSG30: Treating Primary Testicular DLBCL

Dr Annarita Conconi summarizes the results of the Phase II IELSG30 trial assessing R-CHOP, intravenous methotrexate, liposomal cytarabine, and scrotal irradiation in patients with primary DLBCL of the testis.

First-in-Human Trial of ALLO-501A in R/R Large B-cell Lymphoma

Dr Michael Tees discusses the first-in-human data of ALLO-501A, an allogeneic CAR-T product under investigation in relapsed/refractory large B-cell lymphoma in the ALPHA2 study.

Sequencing Treatment Options in Primary Refractory DLBCL


Davies begins by outlining a specific patient case, caveats in the current treatment options for DLBCL, and the patterns of primary refractory DLBCL.

Which New Therapeutics Are Generating Excitement at This Year’s ICML?

Dr Salles summarizes preclinical data on a histone deacetylase inhibitor investigated for T-cell lymphoma, as well as data on bispecific antibodies investigated for DLBCL.

R-CHOP Dose Intensity and Survival Outcomes in DLBCL

Chan Yoon Cheah, MBBS, discusses the results of a systematic review investigating the impact of R-CHOP dose intensity on survival outcomes in patients with DLBCL.


Lung Cancer + Radiation Oncology

Future Perspectives on Radiation Oncology in Lung Cancer

Dr Umberto Ricardi discusses the management of patients with lung cancer who have brain metastases and the importance of precision medicine in treating these patients.

Advances in Radiation Therapy in Stage III NSCLC

Oncology specialists from a lung multidisciplinary team discuss challenges associated with radiation therapy in Stage III NSCLC.

Patterns of Relapse After Radiotherapy in SCLC and Future Treatment Strategies

Dr Sanjay Popat discusses the findings of a subset analysis of the CONVERT trial investigating patterns of relapse following thoracic radiotherapy in patients with limited-stage SCLC.

Updates in Radiotherapy at ELCC 2021

In this discussion, Dr Umberto Ricardi outlines the latest developments in RT for patients with lung cancer, highlighting the ability to improve treatment of brain metastases with radiosurgery...

Global Access to Radiotherapy for Lung Cancer

This webinar describes the current landscape and challenges to deliver RT for lung cancer, with an emphasis on low-and middle-income countries and geographically underserved regions of high-income countries.



Sotorasib For KRAS G12C-Mutated Lung Cancer

Dr Sarah B. Goldberg discusses sotorasib for KRAS G12C-Mutated lung cancer.

Lung Cancer Trial Updates at ASCO 2021

Dr Benjamin Besse discusses results from lung cancer trials that are anticipated in 2021.

Predicting Outcomes of Advanced NSCLC Patients Treated With PD-1/PDL

Dr Gilberto de Lima Lopes Jr discusses "Predicting Outcomes of Advanced NSCLC Patients Treated With PD-1/PDL."

WCLC 2020: Updates From the CHRYSALIS Trial And What it Means for Patients With NSCLC

In this expert discussion Dr Joshua Bauml and Dr Joshua Sabari speak about the updates from the CHRYSALIS trial and what it means for patients with NSCLC.

5-Year Survival Outcomes From The PACIFIC Trial

Dr David R. Spigel presents five-year survival outcomes from the PACIFIC trial, a placebo-controlled Phase III study of patients with unresectable stage III NSCLC who were treated with durvalumab.

Surgical Endpoints Are Needed in Lung Cancer Trials of Neoadjuvant Therapy

Dr Jonathan Spicer highlights the importance of introducing new endpoints in clinical trials of neoadjuvant approaches for lung cancer.


Sickle Cell Anemia

Sickle Cell Disease Overview

Dr Kerry Morrone discusses what causes sickle cell disease, the signs, and symptoms and how to diagnosis it.

Sickle Cell Disease: Ask Dr Susmita Sarangi

Dr Susmita Sarangi is a pediatric hematologist/oncologist in the MedStar Georgetown University Hospital Division of Pediatric, Adolescent, and Young Adult Hematology and Oncology.

Clinical Research and Sickle Cell Disease

This discussion explores issues in sickle cell disease clinical research from the participant's perspective.

Sickle Cell Disease and COVID-19

Dr John Whyte speaks with Dr Wanda Whitten-Shurney, CEO and Medical Director of the Michigan Chapter of the SCDAA, and Clifton R. Kirkman II, a sickle cell warrior, about the impact...

NHS Approves 'Life Changing' Sickle Cell Disease Drug

A new treatment for sickle cell disease has been hailed as a "revolution" for sufferers. The condition is serious and lifelong and can cause severe pain and organ failure - and those who have it end up in hospital often.

Colorectal Cancer and Immunotherapy with Dr. Scott Kopetz

Dr. Scott Kopetz discusses the latest breakthroughs and future promise of immunotherapy for colorectal cancer patients.


source list reference

rgb(171, 222, 222)
200, 66, 245
rgb(195, 2, 230)
rgb(209, 15, 15)
rgb(115, 43, 196)
rgb(9, 151, 227)
rgb(242, 0, 137)
rgb(48, 38, 189)
rgb(231, 165, 240)
rgb(230, 21, 49)
rgb(156, 242, 7)
rgb(224, 4, 129)
rgb(80, 147, 199)
rgb(5, 235, 235)
rgb(235, 190, 9)
rgb(209, 227, 11)
200, 66, 245
rgb(217, 7, 192)
rgb(2, 230, 230)